Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
The Fly
AbbVie, IGI Therapeutics announce licensing agreement for ISB 2001
2d ago
ABBV
Premium
The Fly
AbbVie, Ichnos Glenmark Innovation enter exclusive licensing agreement
2d ago
ABBV
Premium
Ratings
AbbVie: A Strong Buy with Promising Growth Prospects and Stable Outlook
2d ago
ABBV
Premium
Ratings
AbbVie Buy Rating Supported by Strong Performance, Growth Prospects, and Strategic Positioning
3d ago
ABBV
Premium
Ratings
AbbVie’s Strategic Acquisition of Capstan Therapeutics: A Buy Rating Supported by Innovative CAR-T Therapy Platform and Expanding Therapeutic Reach
10d ago
ABBV
Premium
Ratings
AbbVie’s Strategic Growth and Resilience: A Buy Rating Backed by Key Acquisitions and Product Performance
11d ago
ABBV
Premium
Ratings
AbbVie’s Strategic Acquisition of Capstan Therapeutics: A High-Risk, High-Reward Move in Immunology
12d ago
ABBV
Premium
The Fly
AbbVie’s Allergan: FDA accepts sPMA for SKINVIVE by JUVEDERM
12d ago
ABBV
Premium
The Fly
AbbVie to acquire Capstan Therapeutics for $2.1B in cash at closing
12d ago
ABBV
Premium
The Fly
AbbVie to acquire Capstan Therapeutics for $2.1B in cash at closing
12d ago
ABBV
Premium
The Fly
AbbVie reports results from Phase 3 TEMPLE multicenter study
24d ago
ABBV
Premium
The Fly
Roche, AbbVie say Phase III VERONA study faliled in MDS
26d ago
ABBV
CHRO
Premium
The Fly
Roche, AbbVie says Phase III VERONA study faliled in MDS
26d ago
ABBV
CHRO
Premium
The Fly
AbbVie says Phase 3 Verona trial of venetoclax/azacitidine did not meet endpoint
26d ago
ABBV
Premium
Ratings
AbbVie’s Promising Growth: A Buy Rating Backed by Robust R&D and Strategic Advancements
29d ago
ABBV
Premium
Ratings
Balanced Outlook for AbbVie: Hold Rating Amid Opportunities and Challenges
29d ago
ABBV
Premium
The Fly
AbbVie announces FDA approval for MAVYRET expanded indication
1M ago
ABBV
Premium
The Fly
AbbVie call volume above normal and directionally bullish
1M ago
ABBV
Premium
Ratings
AbbVie’s Promising Growth Trajectory: Strong Pipeline, Strategic Investments, and Global Expansion
1M ago
ABBV
Premium
The Fly
AbbVie announces multi-year partnership with the Chicago Cubs
1M ago
ABBV
Premium
The Fly
AbbVie put volume heavy and directionally bearish
1M ago
ABBV
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
BMY
ABBV
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
